by GlobeNewsWire | Jun 22, 2016 | Globe Newswire
Data Presented at the 20th International Congress of Parkinson’s Disease & Movement Disorders in Berlin, Germany VY-AADC01 Continues to Demonstrate Safety with Increasing Coverage of Targeted Regions of the Brain Phase 1b Study On Track to Report Interim Motor...
by GlobeNewsWire | Jun 20, 2016 | Globe Newswire
PHILADELPHIA, June 20, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics, Inc. (“Spark”) (NASDAQ:ONCE) announced today the closing of its previously announced underwritten public offering of common stock pursuant to an automatically effective shelf registration...
by GlobeNewsWire | Jun 14, 2016 | Globe Newswire
PHILADELPHIA, June 14, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics, Inc. (“Spark”) (NASDAQ:ONCE) announced today the pricing of an underwritten public offering of 3,500,000 shares of its common stock pursuant to an automatically effective shelf registration...
by GlobeNewsWire | Jun 13, 2016 | Globe Newswire
PHILADELPHIA, June 13, 2016 (GLOBE NEWSWIRE) — Spark Therapeutics, Inc. (“Spark”) (NASDAQ:ONCE) announced today that it has commenced an underwritten public offering of 3,500,000 shares of its common stock pursuant to an automatically effective shelf...
by GlobeNewsWire | Jun 13, 2016 | Feature Box, Featured, FP, Globe Newswire
Fibrocell Science, Inc. (NASDAQ:FCSC), an autologous cell and gene therapy company translating personalized biologics into medical breakthroughs for diseases affecting the skin, connective tissue and joints, today announced the initiation of adult patient recruitment...